Incyte

Delaware
Pharmaceuticals Biotechnology and Life Sciences

Corporate Bias Rating

Expand Summary

Risk Level:

Rating - Caution
Medium Risk

Summary:

Incyte, a biopharmaceutical company, does not provide viewpoint protections for its employees. However, it has not publicly terminated business relationships based on views or beliefs. Incyte provides a benefits package for employees which covers transgender medical procedures for covered employees and dependents, including children. Incyte discriminates against religious organizations in its charitable giving. The company appears to prioritize diversity over merit in its business structure, including its hiring, employee retention, and supply chain. However, it has not used its reputation or lobbying for ideological purposes. For these reasons, Incyte receives a Medium Risk rating.

View Full Corporate Bias Ratings Report
Generate Reports
Clear
Toast